Skip to main content
. 2012 Oct 3;32(40):13709–13717. doi: 10.1523/JNEUROSCI.2042-12.2012

Table 1.

Levels (ng/mg wet tissue weight) of 5-HT, 5-HIAA, DA, and NE in the insular cortex, dorsal striatum, medial prefrontal cortex, and hippocampus following 5,7-DHT treatment

Structure/Group 5-HT 5-HIAA DA NE
Insular cortex
    Sham 0.2731 ± 0.0479 0.1610 ± 0.0302 0.0886 ± 0.0270 0.1904 ± 0.0284
    Lesion 0.0617 ± 0.0183 0.0639 ± 0.0051 0.0536 ± 0.0097 0.1869 ± 0.0120
    Percent depletion 76%*** 60%* 29% 2%
Dorsal striatum
    Sham 0.3213 ± 0.0208 0.3270 ± 0.0204 4.0486 ± 1.1504 0.2463 ± 0.0388
    Lesion 0.2698 ± 0.0222 0.3136 ± 0.0230 4.9253 ± 1.2689 0.1713 ± 0.0317
    Percent depletion 16% 4% −17% 30%
mPFC
    Sham 0.1228 ± 0.0224 0.2181 ± 0.0414 0.1006 ± 0.0321 0.2286 ± 0.0341
    Lesion 0.1051 ± 0.0160 0.2861 ± 0.0429 0.0743 ± 0.0069 0.2816 ± 0.0228
    Percent depletion 14% −14% 26% 3%
Hippocampus
    Sham 0.2754 ± 0.0138 0.1770 ± 0.0074 0.0101 ± 0.0010 0.2812 ± 0.0190
    Lesion 0.2472 ± 0.0202 0.1846 ± 0.0147 0.0104 ± 0.0010 0.2467 ± 0.0169
    Percent depletion 11% −4% −3% 12%

mPFC, Medial prefrontal cortex; 5-HT, serotonin; 5-HIAA, 5-hydroxyindole acetic acid; DA, dopamine; NE, norepinephrine; 5,7-DHT, 5,7-dihydroxytryptamine.

***p < 0.001;

*p < 0.025.